Adagene Analyst Price Targets

Wall Street analyst price targets and consensus rating for Adagene (ADAG).

Price Target Range — 9 Quarters

Analyst Consensus — 5 Analysts

5Buy

Consensus RatingBuy# Analysts5Avg. Consensus PT$8Upside to Avg. PT+245.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 19, 2026	HC Wainwright & Co.	Arthur He	Maintained	Buy	$7
Sep 14, 2026	HC Wainwright & Co.	Arthur He	Maintained	Buy	$7
Sep 10, 2026	Chardan Capital	Gautam Chukka	Initiate	Buy	$9
Apr 6, 2026	Guggenheim	Paul Jeng	PT Raise	Buy	$9→$10
Nov 24, 2025	Guggenheim	Paul Jeng	Initiate	Buy	$9
Sep 18, 2025	LUCID CAPITAL MARKETS	Christopher Liu	Initiate	Buy	$9
Aug 15, 2025	HC Wainwright & Co.	Arthur He	PT Cut	Buy	$8→$7
Aug 6, 2025	Leerink Partners	Daina Graybosch	Initiate	Outperform	$7
Apr 3, 2025	HC Wainwright & Co.	Arthur He	Maintained	Buy	$8
Jan 27, 2025	HC Wainwright & Co.	Arthur He	PT Raise	Buy	$5→$8
Sep 18, 2024	HC Wainwright & Co.	Arthur He	Maintained	Buy	$5
Jul 22, 2024	HC Wainwright & Co.	Arthur He	Maintained	Buy	$5
Jun 28, 2024	HC Wainwright & Co.	Arthur He	Maintained	Buy	$5

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Adagene, Maintains $7 Price Target

HC Wainwright & Co. analyst Arthur He reiterates Adagene (NASDAQ:ADAG) with a Buy and maintains $7 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Adagene, Maintains $7 Price Target

HC Wainwright & Co. analyst Arthur He reiterates Adagene (NASDAQ:ADAG) with a Buy and maintains $7 price target.

Benzinga Newsdesk

PRO
Chardan Capital Initiates Coverage On Adagene with Buy Rating, Announces Price Target of $9

Chardan Capital analyst Gautam Chukka initiates coverage on Adagene (NASDAQ:ADAG) with a Buy rating and announces Price Target of $9.

Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on Adagene, Raises Price Target to $10

Guggenheim analyst Paul Jeng maintains Adagene (NASDAQ:ADAG) with a Buy and raises the price target from $9 to $10.

Benzinga Newsdesk

PRO
Guggenheim Initiates Coverage On Adagene with Buy Rating, Announces Price Target of $9

Guggenheim analyst Paul Jeng initiates coverage on Adagene (NASDAQ:ADAG) with a Buy rating and announces Price Target of $9.

Benzinga Newsdesk

PRO
LUCID CAPITAL MARKETS Initiates Coverage On Adagene with Buy Rating, Announces Price Target of $9

LUCID CAPITAL MARKETS analyst Christopher Liu initiates coverage on Adagene (NASDAQ:ADAG) with a Buy rating and announces Price Target of $9.

Benzinga Newsdesk

Adagene Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Adagene Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Adagene, Maintains $7 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Adagene, Maintains $7 Price Target

PRO
Chardan Capital Initiates Coverage On Adagene with Buy Rating, Announces Price Target of $9

PRO
Guggenheim Maintains Buy on Adagene, Raises Price Target to $10

PRO
Guggenheim Initiates Coverage On Adagene with Buy Rating, Announces Price Target of $9

PRO
LUCID CAPITAL MARKETS Initiates Coverage On Adagene with Buy Rating, Announces Price Target of $9

People Also Watch

People Also Watch

Adagene Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Adagene Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Reiterates Buy on Adagene, Maintains $7 Price Target

PROHC Wainwright & Co. Reiterates Buy on Adagene, Maintains $7 Price Target

PROChardan Capital Initiates Coverage On Adagene with Buy Rating, Announces Price Target of $9

PROGuggenheim Maintains Buy on Adagene, Raises Price Target to $10

PROGuggenheim Initiates Coverage On Adagene with Buy Rating, Announces Price Target of $9

PROLUCID CAPITAL MARKETS Initiates Coverage On Adagene with Buy Rating, Announces Price Target of $9

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Reiterates Buy on Adagene, Maintains $7 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Adagene, Maintains $7 Price Target

PRO
Chardan Capital Initiates Coverage On Adagene with Buy Rating, Announces Price Target of $9

PRO
Guggenheim Maintains Buy on Adagene, Raises Price Target to $10

PRO
Guggenheim Initiates Coverage On Adagene with Buy Rating, Announces Price Target of $9

PRO
LUCID CAPITAL MARKETS Initiates Coverage On Adagene with Buy Rating, Announces Price Target of $9